Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin L Winthrop

Showing results (11-20 of 317) with videos related to

Pageof 32
Sort By:
Annals of the Rheumatic Diseases|August 6, 2020
To immunosuppress: whom, when and how? That is the question with COVID-19Kevin L Winthrop, Xavier Mariette
Seminars in Respiratory and Critical Care Medicine|August 3, 2018
Treatment of Mycobacterium abscessus ComplexLuke Strnad, Kevin L Winthrop
Current Opinion in Rheumatology|March 17, 2026
Advances in the use of Janus kinase inhibitorsStanley Cohen, Kevin L Winthrop
Nature Reviews. Rheumatology|June 26, 2013
Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapyKevin L Winthrop, Michael Iseman
Clinics in Chest Medicine|February 14, 2015
Nontuberculous mycobacteria infections in immunosuppressed hostsEmily Henkle, Kevin L Winthrop
Current Opinion in Rheumatology|November 14, 2009
Update on rheumatic manifestations of infectious diseasesJennifer Becker, Kevin L Winthrop
Nature Reviews. Rheumatology|October 13, 2011
Therapy: Off-label biologics use and infection risk-the great unknownKevin L Winthrop, Josef S Smolen
Annals of the Rheumatic Diseases|April 8, 2022
In the shadow of antibodies: how T cells defend against COVID-19David S Pisetsky, Kevin L Winthrop
Chest|February 10, 2021
You Gotta Make Me See, What Does It Mean to Have an MIC?David E Griffith, Kevin L Winthrop
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2004
Tuberculosis cases associated with infliximab and etanerceptKevin L Winthrop, Jeffrey N Siegel
Pageof 32

Showing results (11-20 of 317) with videos related to

Sort By:
Pageof 32
Annals of the Rheumatic Diseases|August 6, 2020
To immunosuppress: whom, when and how? That is the question with COVID-19Kevin L Winthrop, Xavier Mariette
Seminars in Respiratory and Critical Care Medicine|August 3, 2018
Treatment of Mycobacterium abscessus ComplexLuke Strnad, Kevin L Winthrop
Current Opinion in Rheumatology|March 17, 2026
Advances in the use of Janus kinase inhibitorsStanley Cohen, Kevin L Winthrop
Nature Reviews. Rheumatology|June 26, 2013
Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapyKevin L Winthrop, Michael Iseman
Clinics in Chest Medicine|February 14, 2015
Nontuberculous mycobacteria infections in immunosuppressed hostsEmily Henkle, Kevin L Winthrop
Current Opinion in Rheumatology|November 14, 2009
Update on rheumatic manifestations of infectious diseasesJennifer Becker, Kevin L Winthrop
Nature Reviews. Rheumatology|October 13, 2011
Therapy: Off-label biologics use and infection risk-the great unknownKevin L Winthrop, Josef S Smolen
Annals of the Rheumatic Diseases|April 8, 2022
In the shadow of antibodies: how T cells defend against COVID-19David S Pisetsky, Kevin L Winthrop
Chest|February 10, 2021
You Gotta Make Me See, What Does It Mean to Have an MIC?David E Griffith, Kevin L Winthrop
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2004
Tuberculosis cases associated with infliximab and etanerceptKevin L Winthrop, Jeffrey N Siegel
Pageof 32